Betamethasone Valerate

Spécifications

2152-44-5Numéro CAS

218-439-3Numéro CE

[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] pentanoateNom IUPAC

C27H37FO6Formule chimique

476.6 g/molMasse molaire

BETAMETHASONE VALERATE; Betamethasone 17-valerate; 2152-44-5; Valisone; Betaderm; Luxiq; beta-Val; Tokuderm; Betatrex; Dermabet; Valnac; Rinderon V; Bextasol; Stanoval; DTXSID7022673; Bettamousse; Betamethasone (as valerate); 9IFA5XM7R2; Betamethasoni valeras; NSC-755912; DTXCID702673; CHEBI:31277; 9-fluoro-11beta,21-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-((1-oxopentyl)oxy)-, (11beta,16beta)-; Betamethasone 17 Valerate; 17-Valerate, Betamethasone; Flubenisolonvalerate; Valerate, Betamethasone; Audavate; Betesil; Fucibet; Xemacort; Audavate rd; Betnovate rd; RefChem:54532; Betameth val in coal tar; Betamethasone Valerate Foam; 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-pentanoate; Betnovate; Bedermin; Celestoderm; Betneval; Dermosol; Dermovaleas; Betamethasone 17a-valerate; MFCD00867446; Ecoval 70; Betamethasone valerate (Betnovate); C27H37FO6; 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-valerate; [(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] pentanoate; Betnovateat; Betamethasone-17-valerate; Betnesol-V; Celeston valerate; beta-Methasone 17-valerate; 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione-17-valerate; 9-fluoro-11beta,21-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl valerate; (2S,10S,11S,13S,15S,17S,1R,14R)-1-fluoro-17-hydroxy-14-(2-hydroxyacetyl)-2,13, 15-trimethyl-5-oxotetracyclo[8.7.0.0<2,7>.0<11,15>]heptadeca-3,6-dien-14-yl pe ntanoate; Topagen (Veterinary); Gentocin (Veterinary); Betaval; Fuciderm; Betoid; Celestoderm V; Celestoderm-V; Betnesol V; Celestan V; Celestan-V; Celestane V; NCGC00274064-01; PREGNA-1,4-DIENE-3,20-DIONE, 9-FLUORO-11,21-DIHYDROXY-16-METHYL-17-((1-OXOPENTYL)OXY)-, (11.BETA.,16.BETA.)-; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-[(1-oxopentyl)oxy]-, (11.beta.,16.beta.)-; EINECS 218-439-3; Rinderon-V (TN); betamethasone-valerate; Luxiq (TN); Topagen (Salt/Mix); Beta-Val (TN); Betatrex (Salt/Mix); Gentocin (Salt/Mix); Betamethason-17-valerat; Betamethason-17-valerate; Betamethasone valerate RS; UNII-9IFA5XM7R2; SCHEMBL7270; CHEMBL1497; Betamethasone 17alpha-valerate; Betamethasone 17-valerate CRS; orb1309553; orb3025856; HY-B0727R; Betamethasone valerate (Standard); MSK2235; GLXC-23436; HY-B0727; Betamethasone valerate (JP18/USP); BETAMETHASONE VALERATE [JAN]; Tox21_302288; BETAMETHASONE VALERATE [USAN]; s1690; BETAMETHASONE VALERATE [VANDF]; AKOS015994704; BETAMETHASONE VALERATE [MART.]; BETAMETHASONE VALERATE [USP-RS]; BETAMETHASONE VALERATE [WHO-DD]; BETAMETHASONE VALERATE [WHO-IP]; CCG-269509; FB18564; KS-1198; NSC 755912; 9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione-17-valerate; BETAMETHASONE 17-VALERATE [MI]; Betamethasone valerate [USAN:USP:JAN]; NCGC00178423-08; NCGC00255185-01; ST075178; SY074182; BETAMETHASONE VALERATE [GREEN BOOK]; CAS-2152-44-5; BETAMETHASONE VALERATE [ORANGE BOOK]; BETAMETHASONE VALERATE [EP MONOGRAPH]; BETAMETHASONI VALERAS [WHO-IP LATIN]; CS-0009628; NS00006017; T1163; BETAMETHASONE VALERATE [USP MONOGRAPH]; 9?-Fluoro-16?-methylprednisolone 17-valerate; A12274; D01357; AB01274710-01; AB01274710_02; Betamethasone valerate for system suitability CRS; F801809; Betamethasone Valerate (Betamethasone 17-Valerate); Q6445931; BRD-K34032314-001-02-5; BRD-K34032314-001-04-1; Betamethasone Valerate Working Standard (Secondary Reference Standard); 9-Fluoro-11?,17,21-trihydroxy-16?-meth ylpregna-1,4-diene-3,20-dione 17-valerate; (11.beta.,16.beta.)-9.alpha.-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 17.alpha.-valerate; (11?,16?)-9-Fluoro-11,21-dihydroxy-16-methyl-17-[(1-oxopentyl)oxy]pregna-1,4-diene-3,20-dione; (11beta,16beta)-9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate; (8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl pentanoate; 9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17-valerate; 9-Fluoro-11.beta.,21-dihydroxy-16.beta.-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate #; Betamethason 17-valarateSynonymes